SCHEMBL28537481

SCHEMBL28537481

CCC(=O)Oc1[nH]nnc1C

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
ESR1 P03372 2/20 0.33
HIF1A Q16665 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PDE4D Q08499 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ELANE P08246 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28522714 0.80 ESR1 (0.33) ACHECA12CA1CA2CA9
SCHEMBL10655346 0.74 ELANE (0.38) ESR1SMN1; SMN2LMNAL3MBTL1ELANE
SCHEMBL28527246 0.73 THRB (0.37) HIF1A
SCHEMBL27351614 0.69 KDM4E (0.38) ACHEESR1HIF1ASMN1; SMN2RECQL
SCHEMBL28855448 0.68 KMT2A (0.41) ACHEESR1HIF1ASMN1; SMN2RECQL
SCHEMBL30159199 0.68 KMT2A (0.41) ACHEESR1HIF1ASMN1; SMN2RECQL
SCHEMBL27567008 0.67 MAPT (0.37) ACHESMN1; SMN2PDE4DRECQLKMT2A
SCHEMBL8439406 0.67 KDM4C (0.38) ACHEESR1HIF1ASMN1; SMN2RECQL
SCHEMBL27935866 0.66 KMT2A (0.36) ACHEESR1HIF1ASMN1; SMN2RECQL
SCHEMBL1243155 0.64 HIF1A (0.38) ACHECA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137557-B Nrf2 modulators 葛兰素史密斯克莱知识产权发展有限公司 2021-09-07 CN disclosed
CN-112930347-A Inhibitors of KEAP1-Nrf2 protein-protein interactions 詹森药业有限公司 2021-06-08 CN disclosed
CN-108112251-B NRF2 modulators 葛兰素史克知识产权发展有限公司 2021-03-05 CN disclosed